Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac and Bupivacaine for TAP Block in Children
NCT06267820Phase 2Completed
- Sponsor
- Sohag University
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketorolac in postoperative pain (2 arms), sponsored by Sohag University. Primary endpoints: 1st analgesic requirement at 24 hours and Number of patients who requested analgesia at 24 hours. Started Jun 2023; status: completed.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06267820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06267820.